highly significantp<0.001
Per protocol population positive outcomes were 30/39 (76.9%) for dimeticone and 10/29 (34.5%) for malathion with a more highly significant (p<0.001) difference of 42.4% (20.7% to 64.2%).
Per protocol population positive outcomes were 30/39 (76.9%) for dimeticone and 10/29 (34.5%) for malathion with a more highly significant (p<0.001) difference of 42.4% (20.7% to 64.2%).